AIC
GILD icon

Aurora Investment Counsel’s Gilead Sciences GILD Stock Holding History

Aurora Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,309
Closed -$1.15M – 115
2018
Q1 		$1.15M Sell
15,309
-1,774
-10% -$141K 0.58% 96
2017
Q4 		$1.22M Buy
+17,083
New +$1.3M 0.61% 90

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aurora Investment Counsel's GILD Position: Q2 2018 in Review

Aurora Investment Counsel sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 15,309 shares — an estimated $1.15M sold.

Aurora Investment Counsel first reported a position in GILD in Q4 2017 and held it in 2 quarters. The position peaked at $1.22M in Q4 2017. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Aurora Investment Counsel reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Aurora Investment Counsel sold 15,309 Gilead Sciences shares in Q2 2018, an estimated $1.15M.
  • Aurora Investment Counsel first reported a position in Gilead Sciences in Q4 2017 and held it in 2 quarters.
  • Aurora Investment Counsel's Gilead Sciences position peaked at $1.22M in Q4 2017.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Aurora Investment Counsel's 13F filing for Q2 2018, filed 25 Jul 2018.